Home
Resources
Diseases
COVID-19
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hexavalent vaccines
HPV vaccines
PCV vaccines
RSV vaccines
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Diseases
Measles
Diseases
Measles
SAGE recommendations and background documents
Find out more
2017
∙
SAGE
Measles vaccines: WHO position paper
Download:
EN
FR
Position paper
Measles
2017
∙
SAGE
Should SAGE recommend the removal of the criterion that MCV2 only be given if MCV1 coverage is >80% for the introduction of routine measles second dose as stated in the 2009 measles vaccine position paper?
Download:
EN
Evidence to recommendation table
Measles
2017
∙
SAGE
Safety of the measles vaccine in young children and adolescents
Download:
EN
GRADE
GRADE table
Measles
2017
∙
SAGE
Duration of protection following measles immunization
Download:
EN
GRADE
GRADE table
Measles
2017
∙
SAGE
Effectiveness of measles vaccine in young children and adolescents
Download:
EN
GRADE
GRADE table
Measles
2017
∙
SAGE
Systematic literature review and meta-analyses of the benefits and risks of measles vaccination below 6 months of age
Download:
EN
SAGE background document
Measles
External links
Measles and rubella strategic framework: 2021-2030
Link:
EN
Catch-up vaccination
Link:
EN
Measles Outbreak Guide
Link:
EN
Planning and implementing high-quality supplementary immunization activities for injectable vaccines using an example of measles and rubella vaccines: field guide
Link:
EN
Measles outbreaks strategic response plan: 2021–2023
Link:
EN
Measles Outbreak Toolkit
Link:
EN
Targeted and selective strategies in measles and rubella vaccination campaigns - interim guidance
Link:
EN
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
